Provided by Tiger Fintech (Singapore) Pte. Ltd.

InVivo Therapeutics

0.3207
+0.0000
Volume:- -
Turnover:- -
Market Cap:995.92K
PE:-0.09
High:0.3207
Open:0.3207
Low:0.3207
Close:0.3207
Loading ...
Nov 16, 2021

Major Issues Report

8-K - Current report
Nov 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 05, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]